|
| 35477676 | Hot flash clinical trial baseline measurements: how long is needed? | BMJ Support Palliat Care | 2024 |
| 37867114 | Sexual Dysfunction in Patients With Metastatic Breast Cancer. | Clin Breast Cancer | 2024 |
| 38079601 | International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts. | J Clin Oncol | 2024 |
| 37802882 | Trends in new and persistent opioid use in older adults with and without cancer. | J Natl Cancer Inst | 2024 |
| 37594766 | Satisfaction with Care and Attention to Age-Specific Concerns by Race and Ethnicity in a National Sample of Young Women with Breast Cancer. | J Adolesc Young Adult Oncol | 2024 |
| 38059899 | Pregnancy After Breast Cancer in Young BRCA Carriers: An International Hospital-Based Cohort Study. | JAMA | 2024 |
| 37880931 | Conception and pregnancy among women with a live birth after breast cancer treatment: A survey study of young breast cancer survivors. | Cancer | 2024 |
| 36316813 | Time to cancer treatment and reproductive outcomes after fertility preservation among adolescent and young adult women with cancer. | Cancer | 2023 |
| 37861526 | Longitudinal cognitive function and brain metabolites in women receiving chemotherapy for stage 1 to 3 breast cancer: Observational study. | Medicine (Baltimore) | 2023 |
| 37561108 | Changes in amount and intensity of physical activity over time in breast cancer survivors. | JNCI Cancer Spectr | 2023 |
| 38011567 | Peripheral blood TCR clonotype diversity as an age-associated marker of breast cancer progression. | Proc Natl Acad Sci U S A | 2023 |
| 37696281 | Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial. | Lancet Oncol | 2023 |
| 37991653 | Retrospective cohort study of CDK4/6-inhibitor-induced alopecia in breast cancer patients. | Support Care Cancer | 2023 |
| 37878086 | Work loss and activity impairment due to extended nausea and vomiting in patients with breast cancer receiving CINV prophylaxis. | Support Care Cancer | 2023 |
| 37498410 | Measuring symptoms and toxicities: a 35-year experience. | Support Care Cancer | 2023 |
| 37930033 | Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials. | JNCI Cancer Spectr | 2023 |
| 37722731 | Advances in the care of breast cancer survivors. | BMJ | 2023 |
| 36993608 | Clinical Outcomes and Prognostic Factors in Triple-Negative Invasive Lobular Carcinoma of the Breast. | Res Sq | 2023 |
| 37185922 | Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors. | NPJ Breast Cancer | 2023 |
| 37251618 | Long-term outcomes of intraoperatively-placed applicator brachytherapy for rapid completion of breast conserving treatment: An analysis of a prospective registry data. | Clin Transl Radiat Oncol | 2023 |
| 37016839 | Effects of an educational physical activity intervention in young women with newly diagnosed breast cancer: Findings from the Young and Strong Study. | Cancer | 2023 |
| 37284847 | Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy: A Phase III Randomized, Double-Blind, Placebo-Controlled Trial (ALLIANCE A221602). | Oncologist | 2023 |
| 37210429 | Clinical outcomes and prognostic factors in triple-negative invasive lobular carcinoma of the breast. | Breast Cancer Res Treat | 2023 |
| 37310797 | Quality of Life in Male Breast Cancer: Prospective Study of the International Male Breast Cancer Program (EORTC10085/TBCRC029/BIG2-07/NABCG). | Oncologist | 2023 |
| 37244627 | Postmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported Outcomes. | Int J Radiat Oncol Biol Phys | 2023 |
| 37308123 | Real-World Implementation of Best-Evidence Cancer Distress Management: Truly Comprehensive Cancer Care. | J Natl Compr Canc Netw | 2023 |
| 37305569 | Replication of genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial. | Front Oncol | 2023 |
| 37133584 | Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer. | N Engl J Med | 2023 |
| 37097406 | An evaluation of the effect of lithium on taxane-induced neuropathy. | Support Care Cancer | 2023 |
| 37364233 | Genomics of <i>ERBB2</i>-Positive Breast Cancer in Young Women Before and After Exposure to Chemotherapy Plus Trastuzumab. | JCO Precis Oncol | 2023 |
| 37197528 | Developing & integrating a mobile application tool into a survivorship clinic for esophageal cancer patients. | J Thorac Dis | 2023 |
| 36624460 | Pragmatic cluster randomized trial to evaluate effectiveness and implementation of EHR-facilitated collaborative symptom control in cancer (E2C2): addendum. | Trials | 2023 |
| 36521077 | Local/Regional Recurrence Rates After Breast-Conserving Therapy in Patients Enrolled in Legacy Trials of the Alliance for Clinical Trials in Oncology (AFT-01). | Ann Surg | 2023 |
| 36623243 | Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in <i>ATM</i>, <i>BRCA1</i>, <i>BRCA2</i>, <i>CHEK2</i>, and <i>PALB2</i>. | J Clin Oncol | 2023 |
| 36693773 | Dexamethasone to prevent everolimus-induced stomatitis (Alliance MIST Trial: A221701). | Semin Oncol | 2023 |
| 36746735 | Underutilization of pretreatment fertility preservation counseling in reproductive-age women with gastrointestinal cancer. | Eur J Surg Oncol | 2023 |
| 36436128 | Adjuvant endocrine therapy non-initiation and non-persistence in young women with early-stage breast cancer. | Breast Cancer Res Treat | 2023 |
| 36435612 | Evidence-Based Guidance for Breast Cancer Survivorship. | Hematol Oncol Clin North Am | 2023 |
| 36872873 | The influence of anatomic stage and receptor status on first recurrence for breast cancer within 5 years (AFT-01). | Cancer | 2023 |
| 36738867 | Prevalence, Severity, and Co-Occurrence of SPPADE Symptoms in 31,866 Patients With Cancer. | J Pain Symptom Manage | 2023 |
| 36826602 | Hair loss during and after breast cancer therapy. | Support Care Cancer | 2023 |
| 36634607 | Impact of Anti-HER2 Therapy Alone and With Weekly Paclitaxel on the Ovarian Reserve of Young Women With HER2-Positive Breast Cancer. | J Natl Compr Canc Netw | 2023 |
| 36527702 | Duration of Chemotherapy-Induced Nausea and Vomiting (CINV) as a Predictor of Recurrent CINV in Later Cycles. | Oncologist | 2023 |
| 36628811 | Fertility Preferences and Practices Among Young Women With Breast Cancer: Germline Genetic Carriers Versus Noncarriers. | Clin Breast Cancer | 2023 |
| 36040183 | Association of raloxifene and tamoxifen therapy with cognitive performance, odds of mild cognitive impairment, and brain MRI markers of neurodegeneration. | Cancer Med | 2023 |
| 36357711 | Medication delivery factors and adjuvant endocrine therapy adherence in breast cancer. | Breast Cancer Res Treat | 2023 |
| 33378304 | Surgical Treatment After Neoadjuvant Systemic Therapy in Young Women With Breast Cancer: Results From a Prospective Cohort Study. | Ann Surg | 2022 |
| 35775874 | Body weight changes and associated predictors in a prospective cohort of young breast cancer survivors. | Cancer | 2022 |
| 35854417 | Vaginal Estrogen Therapy for the Genitourinary Symptoms of Menopause: Caution or Reassurance? | J Natl Cancer Inst | 2022 |
| 35853817 | Surveillance mammography in older breast cancer survivors: Current practice patterns and patient perceptions. | J Geriatr Oncol | 2022 |